Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Job Description Japan Oncology Marketing Precision Medicine Position Summary The Japan Oncology Marketing Precision Medicine role will lead the development and execution of biomarker and diagnostic commercialization strategies. The role will ensure that biomarker strategy is
Become the operational anchor and “second brain” to CIC’s Founder and Executive Chair. You will protect Tim’s time, preserve context, close loops, and help turn a remarkable range of relationships, ideas, and commitments into action. This